Y-mabs shareholder alert: kaskela law llc announces investigation of y-mabs therapeutics, inc. (ymab) on behalf of the company's long-term shareholders and encourages investors to contact the firm

Philadelphia, pa / accesswire / june 14, 2024 / kaskela law llc announces that it is investigating y-mabs therapeutics, inc. (nasdaq:ymab) ("y-mabs") on behalf of the company's long-term shareholders. recently an amended securities fraud complaint was filed against y-mabs on behalf of certain investors who purchased shares of the company's stock between october 6, 2020, and october 28, 2022.
YMAB Ratings Summary
YMAB Quant Ranking